高级检索
当前位置: 首页 > 详情页

Geriatric Nutritional Risk Index as a prognostic marker for predicting survival outcomes in patients with UTUC after radical nephroureterectomy

文献详情

资源类型:
Pubmed体系:
机构: [1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China. [2]West China School of Medicine, Sichuan University, Chengdu, China. [3]Department of Urology, People’s Hospital of Tibet Autonomous Region, Lhasa, China. [4]Lanzhou New District First People’s Hospital, Lanzhou, Gansu, China. [5]Department of General Surgery, The Second People’s Hospital of Dingxi, Dingxi, Gansu, China.
出处:

关键词: Geriatric nutritional risk index Upper tract urothelial carcinoma Prognosis Nomogram

摘要:
The purpose of this study was to determine the prognostic value of the Geriatric Nutritional Risk Index (GNRI) in patients with upper tract urothelial carcinoma (UTUC) after radical nephrectomy (RNU). A retrospective study of UTUC patients was conducted at West China Hospital between May 2016 and June 2019. The optimal cut-off point for GNRI was determined using the X-Tile procedure. Univariate and multivariate analyses were performed to identify predictors, and two- and four-year cancer-specific survival (CSS) prediction nomograms were created based on the results of the multivariate analyses. Furthermore, time-dependent ROC curve, calibration curve and decision curve analyses were conducted. A total of 219 patients with UTUC following RNU were identified and subsequently divided into three groups based on the critical values of GNRI (91.2, 98.8). GNRI was identified as a significant risk factor for CSS, with patients exhibiting higher GNRI demonstrating elevated CSS (hazard ratio = 0.58; 95% confidence interval, 0.32-0.92; P = 0.037). Furthermore, the GNRI-based nomogram demonstrated high predictive capacity for CSS, with areas under the curve of 0.810 and 0.842 for 2- and 4-year CSS, respectively. Preoperative GNRI is an independent predictor for CSS in UTUC patients who underwent RNU and should be considered as a promising personalized tool for clinical decision-making.© 2025. The Author(s).

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
最新[2025]版:
大类 | 3 区 综合性期刊
小类 | 3 区 综合性期刊
第一作者:
第一作者机构: [1]Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu 610041, China. [2]West China School of Medicine, Sichuan University, Chengdu, China. [3]Department of Urology, People’s Hospital of Tibet Autonomous Region, Lhasa, China.
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:55350 今日访问量:0 总访问量:4686 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号